Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Weekly shot may help teens fight obesity long-term

NCT ID NCT06571383

Disease control Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a weekly injection of semaglutide can help 500 adolescents with obesity lose weight and maintain that loss for at least 3 years. All participants receive the medicine, which is injected into the stomach, thigh, or upper arm. The goal is to see if the drug keeps BMI below the obesity threshold over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Nov 2031

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 15 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Informed consent obtained before any study-related activities. Study-related activities are any procedures that are carried out as part of the study, including activities to determine suitability for the study: 1. The parent(s) or legally acceptable representative (LAR) of the participant must sign and date the Informed Consent Form, according to local requirements 2. The participant must sign and date the Child Assent Form or provide oral assent, according to local requirements * Age 12 to less than 15 years at the time of signing the informed consent * BMI greater than or equal to 95th percentile at screening * Body weight greater than 60 kg at screening Exclusion criteria: * Prepubertal status (Tanner stage 1) * Treatment with any medication prescribed for the indication of obesity or weight management within 90 days before screening * Previous or planned (during the study period) obesity treatment with surgery or a weight loss device. However, the following are allowed: 1. Liposuction and/or abdominoplasty, if performed more than 1 year prior to screening 2. Adjustable gastric banding, if the band has been removed more than 1 year prior to screening 3. Intragastric balloon, if the balloon has been removed more than 1 year prior to screening 4. Duodenal-jejunal bypass liner (e.g., Endobarrier), if the sleeve has been removed more than 1 year prior to screening * Endocrine, hypothalamic, or syndromic obesity * History of type 1 or type 2 diabetes mellitus

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obesity

Contacts and locations

Locations

  • 'Ippokrateio' General Hospital of Thessaloniki

    Thessaloniki, 546-42, Greece

  • Aalborg Universitetshospital - Børne og Ungeafdelingen

    Gistrup, 9260, Denmark

  • Aarhus Universitetshospital, Steno Diabetes Center Aarhus

    Aarhus, 8200, Denmark

  • Alberta Children's Hospital

    Calgary, Alberta, T3B6A8, Canada

  • Alder Hey Children's Hospital

    Liverpool, L12 2AP, United Kingdom

  • Ap-Hp_Hopital Armand Trousseau

    Paris, 75012, France

  • Auf der Bult - Klinik für Diabetologie, Endokrinologie, Gastroenterologie und Klinische Forschung

    Hanover, 30173, Germany

  • Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Civile Maggiore Borgo Trento

    Verona, 37126, Italy

  • BC Children's Hospital

    Vancouver, British Columbia, V6H 3V4, Canada

  • Barry J. Reiner, MD LLC

    Baltimore, Maryland, 21229, United States

  • Birmingham Children's Hospital

    Birmingham, B4 6NH, United Kingdom

  • CHRISTUS - Latam Hub Excellence and Innovation Center

    Monterrey, Nuevo León, 64060, Mexico

  • Centre Hospitalier Universitaire de Lille-Hopital Jeanne de Flandre

    Lille, 59037, France

  • Centre Hospitalier Universitaire de Rouen-Hopital Charles Nicolle

    Rouen, 76031, France

  • Centricity Research - Ohio

    Columbus, Ohio, 43213, United States

  • Centro de Estudios de Investigación Metabólicos y Cardio

    Ciudad Madero, Tamaulipas, 89440, Mexico

  • Children's Healthcare Atlanta

    Atlanta, Georgia, 30329, United States

  • Clinical Neuroscience Solution

    Orlando, Florida, 32801, United States

  • Clinical Neuroscience Solutions

    Memphis, Tennessee, 38119, United States

  • Clinical Trials of Texas Inc

    San Antonio, Texas, 78229, United States

  • Cliniques universitaires Saint-Luc

    Brussels, 1200, Belgium

  • Coastal Carolina Research Ctr

    North Charleston, South Carolina, 29405, United States

  • Columbus Research Foundation

    Columbus, Georgia, 31904, United States

  • Consultorio de Endocrinología y Pediatría

    Puebla City, 72190, Mexico

  • Copernicus Podmiot Leczniczy Sp. z o.o.

    Gdansk, 80-803, Poland

  • ELIPSA - Elzbieta Lipska praktyka lekarska Osrodek Endokrynologii i Diabetologii Dzieciecej

    Stanisławow Pierwszy Nieporet, 05-126, Poland

  • Eastside Bariatric and Gen Surg

    Snellville, Georgia, 30078, United States

  • Falu Lasarett - Barn- och ungdomsmedicinsk mottagning

    Falun, 791 37, Sweden

  • Fondation Lenval Nice

    Nice, 06200, France

  • General University of Patra - Paediatric Department

    Pátrai, 26504, Greece

  • Górnośląskie Centrum Zdrowia Dziecka Im. Św. Jana Pawla II Samodzielny Publiczny Szpital Kliniczny Nr 6 SUM w Katowicach

    Katowice, 40-752, Poland

  • Hallands sjukhus Halmstad

    Halmstad, 30233, Sweden

  • Hannoversche Kinderheilanstalt "Auf der Bult" - Diabeto-, Endokrino-, Gastroenterologie und Klinische Forschung

    Hanover, 30173, Germany

  • Health Res of Hampton Roads

    Newport News, Virginia, 23606, United States

  • Holbæk Sygehus - Børne- og Ungeafdelingen

    Holbæk, 4300, Denmark

  • Hopital Des Enfants

    Toulouse, 31059, France

  • IRCCS Meyer Firenze

    Florence, Tuscany, 50139, Italy

  • IRCCS materno infantile Burlo Garofolo - Clinica Pediatrica

    Trieste, 34137, Italy

  • Indiana University Hospital

    Indianapolis, Indiana, 46505, United States

  • Instytut ''Pomnik - Centrum Zdrowia Dziecka''

    Warsaw, 04-730, Poland

  • Ippokrateio Gen Hosp of Thessaloniki, 1st Pediatric Clinic

    Thessaloniki, 54642, Greece

  • Kath. Klinikum Bochum gGmbH - Kinderklinik St. Josef-Hospital

    Bochum, 44791, Germany

  • King Abdulaziz Hospital-Al Ahsa-National Guard

    Al Ahsa, 36428, Saudi Arabia

  • King Faisal Specialist Hospital & Research Centre, Riyadh

    Riyadh, 12713, Saudi Arabia

  • King Khaled University Hospital,King Saud Univ. Med. City

    Riyadh, 12372, Saudi Arabia

  • Kliniczny Szpital Wojewodzki nr 2 im. Sw. Jadwigi Krolowej w Rzeszowie

    Rzeszów, 35-301, Poland

  • Klinika Pediatrii, Endokrynologii, Diabetologii I chorób Metabolicznych, Uniwersyteckiego Szpitala Klinicznego in Wrocław

    Wroclaw, Lower Silesian Voivodeship, 50-368, Poland

  • Leeds Children's Hospital

    Leeds, LS1 3EX, United Kingdom

  • Maison de Sante Prevention

    Montreal, Quebec, H2J 1K1, Canada

  • Markham Stouffville Hosp

    Markham, Ontario, L3P 7P3, Canada

  • McGill Uni Health Ctre - Glen Site

    Montreal, Quebec, H4A 3J1, Canada

  • McMaster Children's Hospital

    West Hamilton, Ontario, L8N 3Z5, Canada

  • Mississippi CTR for ADV MED

    Madison, Mississippi, 39110, United States

  • National Guard Hospital - Jeddah

    Jeddah, 22384, Saudi Arabia

  • National Guard Hospital_Riyadh

    Riyadh, 14611, Saudi Arabia

  • Neighborhood Healthcare

    Escondido, California, 92025, United States

  • Ospedale Pediatrico Bambino Gesu

    Roma, 00165, Italy

  • Ospedale dei Bambini "Vittore Buzzi"

    Milan, 20154, Italy

  • P & A Kyriakou Childrens' Hospital - Department of Endocrinology Growth and Development

    Goudi/Athens, 115-27, Greece

  • Pennington Biom Res Ctr

    Baton Rouge, Louisiana, 70808, United States

  • PriMed Clinical Research

    Dayton, Ohio, 45429, United States

  • Samodzielny Publiczny Szpital Kliniczny Nr 1 im. Prof. Szyszko

    Zabrze, 41-800, Poland

  • Sheffield Children's Hospital

    Sheffield, S10 2TH, United Kingdom

  • Skåne US Malmö - Barnöverviktsenheten

    Malmö, 205 02, Sweden

  • Solaris Clinical Research

    Meridian, Idaho, 83646, United States

  • Southampton General Hospital

    Southampton, SO16 6YD, United Kingdom

  • Stollery Children's Hospital

    Edmonton, Alberta, T6G 2B7, Canada

  • Sundsvalls sjukhus - Barn- och ungdomsmed mott

    Sundsvall, 85643, Sweden

  • Synexus Clinical Research US Inc.-Chicago

    Chicago, Illinois, 60602, United States

  • TMH Physician Partners Endo

    Tallahassee, Florida, 32308, United States

  • Texas Diabetes Institute

    San Antonio, Texas, 78207-5209, United States

  • The Hospital for Sick Children

    Toronto, Ontario, M5G 1X8, Canada

  • U.G.H. "Attikon", Pediatric Endocrinology Outpatient Clinic

    Athens, 12462, Greece

  • UBMD Peds-Div of Endo/Diabetes

    Buffalo, New York, 14203, United States

  • UMED Clinical Trials sp. z o.o.

    Lodz, 92-213, Poland

  • UPMC Child Hosp-Pittsburgh

    Pittsburgh, Pennsylvania, 15224, United States

  • UZ Brussel - Universitair Ziekenhuis Brussel

    Brussels, 1090, Belgium

  • UZA - Universitair Ziekenhuis Antwerpen

    Edegem, 2650, Belgium

  • Uni-Med. Göttingen - Klinik für Kinder- und Jugendmedizin

    Göttingen, 37075, Germany

  • Uniklinik Leipzig - Klinik und Poliklinik für Kinder- und Jugendmedizin

    Leipzig, 04103, Germany

  • Uniklinik Ulm - Dt. Zentrum für Kinder- und Jugendgesundheit (DZKJ)

    Ulm, 89075, Germany

  • University College Hospital - Paediatric Services

    London, NW1 1BU, United Kingdom

  • University Hospitals Bristol & Weston NHS Foundation Trust

    Bristol, BS2 8AE, United Kingdom

  • University Of Iowa Hospitals and Clinics

    Iowa City, Iowa, 52242, United States

  • University of Minnesota

    Minneapolis, Minnesota, 55414, United States

  • Universitätsklinikum Leipzig - Klinik und Poliklinik für Kinder- und Jugendmedizin

    Leipzig, 04103, Germany

  • Universitätsklinikum Ulm für Kinder- und Jugendmedizin

    Ulm, 89075, Germany

  • Universitätsmedizin Göttingen - Klinik für Kinder-und Jugendmedizin

    Göttingen, 37075, Germany

  • Uppsala universitetssjukhus

    Uppsala, 75185, Sweden

  • Uz Leuven

    Leuven, 3000, Belgium

  • Valley Weight Loss Clinic

    Fargo, North Dakota, 58104, United States

  • Virginia Commonwealth Univ

    Richmond, Virginia, 23298, United States

  • WakeMed Childn Endo-Dbt_Raleig

    Raleigh, North Carolina, 27610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.